Contact Lens Spectrum

August 2005

Document #117




(p. 23) Contact Lens Care – Caring for Silicone Hydrogel Contact Lenses — Part 3, By Susan J. Gromacki, OD, MS, FAAO




(p. 24) Techniques for Improved Soft Lens Fitting, By Robert L. Davis, OD, FAAO, and P. Douglas Becherer, OD, FAAO


1.  Caroline, André.  The effect of corneal diameter on soft lens fitting, part 1. Contact Lens Spectrum 2002;17(4)56.



(p. 33) No-fee CE: Contemporary Antibiotic and Anti-inflammatory Ocular Drugs, By Robert B. DiMartino, OD, MS, and Meredith M. Whiteside, OD


Bartlett JD, Jaanus SD, Clinical ocular pharmacology, Edition    4th ed., Boston, Butterworth-Heinemann, c2001.


Blondeau JM, Fluoroquinolones: mechanism of action, classification, and development of resistance. Surv Ophthalmol. 2004 Mar;49 Suppl 2:S73-8. Review.


Ciulla TA, Walker JD, Fong DS, Criswell MH. Corticosteroids in posterior segment disease: an update on new delivery systems and new indications.  Curr Opin Ophthalmol. 2004 Jun;15(3):211-20.


Hassan T, Laser, Surgery and Corticocorticosteroids for Diabetic Retinopathy…Times are Changing, Review of Ophthalmology Suppl 10/01/2004 11 (10) 21-24.


Hwang DG, Fluoroquinolone resistance in ophthalmology and the potential role for newer ophthalmic fluoroquinolones. Surv Ophthalmol. 2004 Mar;49 Suppl 2:S79-83. Review.


Sherif Z, Pleyer U, Corticosteroids in Ophthalmology: Past - Present - Future

Ophthalmologica 2002;216:305-315.


Singerman LJ. Pharmacology for age-related macular degeneration. Retina Handbook.  Bloomfield, NJ: Jobson, 2004, pp.12-15.


Sutter, FK, Simpson JM, Gillies MC, Intravitreal triamcinolone for diabetic macular edema that persists after laser treatment: three-month efficacy and safety results of a prospective, randomized, double-masked, placebo-controlled clinical trial. Ophthalmology. 2004 Nov;111(11):2044-9.


Tranos PG, Wickremasinghe SS, Stangos NT, Topouzis F, Tsinopoulos I, Pavesio CE., Macular edema. Surv Ophthalmol. 2004 Sep-Oct;49(5):470-90.  




(p. 42) Use Your Ears to Identify Lens-Related Dryness, By Robin L. Chalmers, OD, and Carolyn G. Begley, OD, MS


1.  In the News:  CIBA Vision study on soft contact lens dropouts.  Optom Vis Sci 2004;81(11)814.


2.  Begley CG, Chalmers RL, Mitchell GL, Nichols KK, Caffery BA, Simpson T, DuToit R, Portello J, Davis L.  Characterization of ocular surface symptoms from optometric practices in North America. Cornea 2001;20(6):610-8.


3.  Chalmers RL, Begley CG, Edrington T, Caffery B, Nelson JD, Snyder C, Simpson T.  The Agreement between Self-Assessment and Clinician Assessment of Dry Eye Severity. Cornea  In Press 2005.


4.  Pritchard N, Fonn D, Brazeau D.  Discontinuation of contact lens wear.  Int Contact Lens Clin. 1999;26:157-61


5.  Young G, Veys J, Pritchard N, Coleman S.  A multi-centre study of lapsed contact lens wearers.  Ophthal Physiol Opt 2002;22:516-27.


6.  Begley, CG, Chalmers RL, Abetz L, Venkataraman K, et al.  The Relationship Between Habitual Patient-Reported Symptoms and Clinical Signs Among Patients with Dry Eye of Varying Severity.   Invest Ophthalmol Vis Sci  2003;44:11;4753-61.


7.  Korb DR.  Survey of preferred tests for diagnosis of the tear film and dry eye. Cornea 2000;19(4):483-6.

8.  Nichols KK, Nichols JJ, Zadnik K.  Frequency of dry eye diagnostic test procedures used in various modes of ophthalmic practice. Cornea 2000;19(4):477-482.



(p. 50) Treatment Plan – Reducing the Risk for AMD, by Leo Semes, OD, FAAO


Vingerling JR, Dielemans I, Hofman A, et al. The prevalence of Age-related Maculopathy in the Rotterdam Study. Ophthalmology 1995; 102 : 205-10.
Ferris III FL, Tielch JM.  Blindness and Visual Impairment A Public Health Issue for the Future as Well as Today. Arch Ophthalmol 2004; 122: 451-452.
Risk Factors
DeBlack SS. Optometry: JAOA 2003;74:99-110
Klein R, et al.  AM J Epdimiol 2002; 156: 589
Mitchell P, et al.  Arch Ophthalmol 2002; 120: 1357
SC, et al. Ophthalmology 2004; 111: 1280

West SK, et al., Arch Ophthaomol 1989; 107: 875.
Cruickshanks KJ, et al., Arch Ophthaomol 1993; 111: 514
Young RW.  Surv Ophthalmol 1988; 32: 252
Mitchell P, et al., Ophthalmology 1998; 105: 1359
Darzins, P, et al. Ophthalmology 1997; 104: 770
Cruickshanks KJ, et al. Arch Ophthalmol 2001; 119: 246.
Mozaffarieh, M. Sacu S, WedrichA. The role of the carotenoids, lutein and zeaxanthin, in protecting against age-related macular degeneration: A review based on controversial evidence. Nutrition Journal 2003; 2:20-32.
AREDS Research Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta-carotene, and zinc for age-related macular degeneration and vision loss. AREDS Report No. 8. Arch Ophthalmol 2001; 119; 1417-1436. Accessed May 25, 2005.